Clinical and Molecular Landscape of ALS Patients with <i>SOD1</i> Mutations: Novel Pathogenic Variants and Novel Phenotypes. A Single ALS Center Study

Mutations in the copper zinc superoxide dismutase 1 (<i>SOD1</i>) gene are the second most frequent cause of familial amyotrophic lateral sclerosis (ALS). Nearly 200 mutations of this gene have been described so far. We report all <i>SOD1</i> pathogenic variants identified in...

Full description

Bibliographic Details
Main Authors: Emilien Bernard, Antoine Pegat, Juliette Svahn, Françoise Bouhour, Pascal Leblanc, Stéphanie Millecamps, Stéphane Thobois, Claire Guissart, Serge Lumbroso, Kevin Mouzat
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/21/18/6807
_version_ 1797553489856954368
author Emilien Bernard
Antoine Pegat
Juliette Svahn
Françoise Bouhour
Pascal Leblanc
Stéphanie Millecamps
Stéphane Thobois
Claire Guissart
Serge Lumbroso
Kevin Mouzat
author_facet Emilien Bernard
Antoine Pegat
Juliette Svahn
Françoise Bouhour
Pascal Leblanc
Stéphanie Millecamps
Stéphane Thobois
Claire Guissart
Serge Lumbroso
Kevin Mouzat
author_sort Emilien Bernard
collection DOAJ
description Mutations in the copper zinc superoxide dismutase 1 (<i>SOD1</i>) gene are the second most frequent cause of familial amyotrophic lateral sclerosis (ALS). Nearly 200 mutations of this gene have been described so far. We report all <i>SOD1</i> pathogenic variants identified in patients followed in the single ALS center of Lyon, France, between 2010 and 2020. Twelve patients from 11 unrelated families are described, including two families with the not yet described <i>H81Y</i> and <i>D126N</i> mutations. Splice site mutations were detected in two families. We discuss implications concerning genetic screening of <i>SOD1</i> gene in familial and sporadic ALS.
first_indexed 2024-03-10T16:16:40Z
format Article
id doaj.art-084a8f0d1e4241d9bcaa3b77204d1b2a
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T16:16:40Z
publishDate 2020-09-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-084a8f0d1e4241d9bcaa3b77204d1b2a2023-11-20T13:59:17ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-09-012118680710.3390/ijms21186807Clinical and Molecular Landscape of ALS Patients with <i>SOD1</i> Mutations: Novel Pathogenic Variants and Novel Phenotypes. A Single ALS Center StudyEmilien Bernard0Antoine Pegat1Juliette Svahn2Françoise Bouhour3Pascal Leblanc4Stéphanie Millecamps5Stéphane Thobois6Claire Guissart7Serge Lumbroso8Kevin Mouzat9Centre SLA de Lyon, Hôpital Neurologique P. Wertheimer, Hospices Civils de Lyon, Université de Lyon, 59 Boulevard Pinel, 69677 Bron CEDEX, FranceCentre SLA de Lyon, Hôpital Neurologique P. Wertheimer, Hospices Civils de Lyon, Université de Lyon, 59 Boulevard Pinel, 69677 Bron CEDEX, FranceCentre SLA de Lyon, Hôpital Neurologique P. Wertheimer, Hospices Civils de Lyon, Université de Lyon, 59 Boulevard Pinel, 69677 Bron CEDEX, FranceCentre SLA de Lyon, Hôpital Neurologique P. Wertheimer, Hospices Civils de Lyon, Université de Lyon, 59 Boulevard Pinel, 69677 Bron CEDEX, FranceInstitut NeuroMyoGène, CNRS UMR5310, INSERM U1217, Faculté de Médecine Rockefeller, Université Claude Bernard Lyon I, 8 Avenue Rockefeller, 69373 Lyon CEDEX 08, FranceInstitut du Cerveau, ICM, Inserm U1127, CNRS UMR7225, Sorbonne Université, Hôpital Pitié-Salpêtrière, 75646 Paris, FranceCentre SLA de Lyon, Hôpital Neurologique P. Wertheimer, Hospices Civils de Lyon, Université de Lyon, 59 Boulevard Pinel, 69677 Bron CEDEX, FranceLaboratoire de Biochimie et Biologie Moleculaire, CHU Nimes, Nimes, Motoneuron Disease: Pathophysiology and Therapy, INM, University Montpellier, 30029 Nîmes CEDEX 9, FranceLaboratoire de Biochimie et Biologie Moleculaire, CHU Nimes, Nimes, Motoneuron Disease: Pathophysiology and Therapy, INM, University Montpellier, 30029 Nîmes CEDEX 9, FranceLaboratoire de Biochimie et Biologie Moleculaire, CHU Nimes, Nimes, Motoneuron Disease: Pathophysiology and Therapy, INM, University Montpellier, 30029 Nîmes CEDEX 9, FranceMutations in the copper zinc superoxide dismutase 1 (<i>SOD1</i>) gene are the second most frequent cause of familial amyotrophic lateral sclerosis (ALS). Nearly 200 mutations of this gene have been described so far. We report all <i>SOD1</i> pathogenic variants identified in patients followed in the single ALS center of Lyon, France, between 2010 and 2020. Twelve patients from 11 unrelated families are described, including two families with the not yet described <i>H81Y</i> and <i>D126N</i> mutations. Splice site mutations were detected in two families. We discuss implications concerning genetic screening of <i>SOD1</i> gene in familial and sporadic ALS.https://www.mdpi.com/1422-0067/21/18/6807amyotrophic lateral sclerosiscopper zinc superoxide dismutase 1<i>SOD1</i>
spellingShingle Emilien Bernard
Antoine Pegat
Juliette Svahn
Françoise Bouhour
Pascal Leblanc
Stéphanie Millecamps
Stéphane Thobois
Claire Guissart
Serge Lumbroso
Kevin Mouzat
Clinical and Molecular Landscape of ALS Patients with <i>SOD1</i> Mutations: Novel Pathogenic Variants and Novel Phenotypes. A Single ALS Center Study
International Journal of Molecular Sciences
amyotrophic lateral sclerosis
copper zinc superoxide dismutase 1
<i>SOD1</i>
title Clinical and Molecular Landscape of ALS Patients with <i>SOD1</i> Mutations: Novel Pathogenic Variants and Novel Phenotypes. A Single ALS Center Study
title_full Clinical and Molecular Landscape of ALS Patients with <i>SOD1</i> Mutations: Novel Pathogenic Variants and Novel Phenotypes. A Single ALS Center Study
title_fullStr Clinical and Molecular Landscape of ALS Patients with <i>SOD1</i> Mutations: Novel Pathogenic Variants and Novel Phenotypes. A Single ALS Center Study
title_full_unstemmed Clinical and Molecular Landscape of ALS Patients with <i>SOD1</i> Mutations: Novel Pathogenic Variants and Novel Phenotypes. A Single ALS Center Study
title_short Clinical and Molecular Landscape of ALS Patients with <i>SOD1</i> Mutations: Novel Pathogenic Variants and Novel Phenotypes. A Single ALS Center Study
title_sort clinical and molecular landscape of als patients with i sod1 i mutations novel pathogenic variants and novel phenotypes a single als center study
topic amyotrophic lateral sclerosis
copper zinc superoxide dismutase 1
<i>SOD1</i>
url https://www.mdpi.com/1422-0067/21/18/6807
work_keys_str_mv AT emilienbernard clinicalandmolecularlandscapeofalspatientswithisod1imutationsnovelpathogenicvariantsandnovelphenotypesasinglealscenterstudy
AT antoinepegat clinicalandmolecularlandscapeofalspatientswithisod1imutationsnovelpathogenicvariantsandnovelphenotypesasinglealscenterstudy
AT juliettesvahn clinicalandmolecularlandscapeofalspatientswithisod1imutationsnovelpathogenicvariantsandnovelphenotypesasinglealscenterstudy
AT francoisebouhour clinicalandmolecularlandscapeofalspatientswithisod1imutationsnovelpathogenicvariantsandnovelphenotypesasinglealscenterstudy
AT pascalleblanc clinicalandmolecularlandscapeofalspatientswithisod1imutationsnovelpathogenicvariantsandnovelphenotypesasinglealscenterstudy
AT stephaniemillecamps clinicalandmolecularlandscapeofalspatientswithisod1imutationsnovelpathogenicvariantsandnovelphenotypesasinglealscenterstudy
AT stephanethobois clinicalandmolecularlandscapeofalspatientswithisod1imutationsnovelpathogenicvariantsandnovelphenotypesasinglealscenterstudy
AT claireguissart clinicalandmolecularlandscapeofalspatientswithisod1imutationsnovelpathogenicvariantsandnovelphenotypesasinglealscenterstudy
AT sergelumbroso clinicalandmolecularlandscapeofalspatientswithisod1imutationsnovelpathogenicvariantsandnovelphenotypesasinglealscenterstudy
AT kevinmouzat clinicalandmolecularlandscapeofalspatientswithisod1imutationsnovelpathogenicvariantsandnovelphenotypesasinglealscenterstudy